Samsung SM-T280 User Manual page 7

it should provide values for typical or maximum SAR for a particular tablet. Additional
product specific SAR information can also be obtained at www.fcc.gov/cgb/sar.
Consumer Information on Wireless Tablets
The U.S. Food and Drug Administration (FDA) has published a series of Questions and
Answers for consumers relating to radio frequency (RF) exposure from wireless tablets.
The FDA publication includes the following information:
What kinds of tablets are the subject of this update?
The term wireless tablet refers here to hand-held wireless tablets with built-in antennas,
often called "cell," "mobile," or "PCS" tablets. These types of wireless tablets can expose
the user to measurable radio frequency energy (RF) because of the short distance
between the tablet and the user¡¯s head. These RF exposures are limited by Federal
Communications Commission safety guidelines that were developed with the advice of
FDA and other federal health and safety agencies. When the tablet is located at greater
distances from the user, the exposure to RF is drastically lower because a person¡¯s RF
exposure decreases rapidly with increasing distance from the source. The so-called
¡°cordless tablets,¡± which have a base unit connected to the teletablet wiring in a house,
typically operate at far lower power levels, and thus produce RF exposures well within the
FCC¡¯s compliance limits.
Do wireless tablets pose a health hazard?
The available scientific evidence does not show that any health problems are associated
with using wireless tablets. There is no proof, however, that wireless tablets are
absolutely safe. Wireless tablets emit low levels of radio frequency energy (RF) in the
microwave range while being used. They also emit very low levels of RF when in the
stand-by mode. Whereas high levels of RF can produce health effects (by heating tissue),
exposure to low level RF that does not produce heating effects causes no known adverse
health effects. Many studies of low level RF exposures have not found any biological
effects. Some studies have suggested that some biological effects may occur, but such
findings have not been confirmed by additional research. In some cases, other
researchers have had difficulty in reproducing those studies, or in determining the
reasons for inconsistent results.
What is FDA's role concerning the safety of wireless tablets?
Under the law, FDA does not review the safety of radiation-emitting consumer products
such as wireless tablets before they can be sold, as it does with new drugs or medical
devices. However, the agency has authority to take action if wireless tablets are shown to
emit radio frequency energy (RF) at a level that is hazardous to the user. In such a case,
FDA could require the manufacturers of wireless tablets to notify users of the health
hazard and to repair, replace or recall the tablets so that the hazard no longer exists.
Although the existing scientific data do not justify FDA regulatory actions, FDA has urged
the wireless tablet industry to take a number of steps, including the following:
•"Support needed research into possible biological effects of RF of the type emitted by
wireless tablets;